Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus – report of 17 cases and review of the literature

Cutaneous manifestations occur frequently in systemic lupus erythematosus (SLE) and are pathognomonic in subacute-cutaneous lupus erythematosus (SCLE) and chronic cutaneous lupus erythematosus (CCLE). Although B-cell depletion therapy (BCDT) has demonstrated efficacy in SLE with visceral involvement...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmann, SC, Leandro, MJ, Morris, SD, Isenberg, DA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107853/
https://www.ncbi.nlm.nih.gov/pubmed/23894047
http://dx.doi.org/10.1177/0961203313497115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107853/
https://www.ncbi.nlm.nih.gov/pubmed/23894047
http://dx.doi.org/10.1177/0961203313497115

Ejemplares similares